Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1Transo-Pharm USA LLC
03 2Bachem AG
04 1HRV Global Life Sciences
05 1ALP Pharm
06 1ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD
07 1Auro Peptides Limited
08 1Aurobindo Pharma Limited
09 1BCN Peptides
10 1Fresenius Kabi AB Brunna
11 1GSK
12 1Hybio Pharmaceutical
13 1ILS Inc
14 1Jin Dun Medical
15 1Mallinckrodt Pharmaceuticals
16 1Peninsula Laboratories
17 1Piramal Pharma Solutions
18 2PolyPeptide Group
19 1Sajjala Bio Labs
20 1Shanghai Soho-Yiming Pharmaceuticals
21 1Shenzhen JYMed Technology
22 1Smaart Pharmaceutticals
23 1UCB Pharma S.A
24 1UGP Pharma
01 1Belgium
02 6China
03 1Egypt
04 1France
05 5India
06 1Ireland
07 1Spain
08 1Sweden
09 4Switzerland
10 4U.S.A
11 1United Kingdom
01 6Active
02 7Inactive
03 13Blank
01 6Valid
02 20Blank
01 1218MF10773
02 1218MF10953
03 1223MF10073
04 23Blank
01 1WC-0237
02 25Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7484
Submission : 1988-05-10
Status : Inactive
Type : II
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-03-27
Pay. Date : 2015-03-18
DMF Number : 6504
Submission : 1986-07-29
Status : Active
Type : II
Certificate Number : R1-CEP 2000-180 - Rev 01
Issue Date : 2008-08-01
Type : Chemical
Substance Number : 471
Status : Valid
Registration Number : 218MF10953
Registrant's Address : 3132 Kashiwa Street, Torrance, California 90505, USA
Initial Date of Registration : 2006-11-24
Latest Date of Registration : --
NDC Package Code : 52416-111
Start Marketing Date : 2009-06-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Certificate Number : R1-CEP 2010-347 - Rev 00
Issue Date : 2016-12-02
Type : Chemical
Substance Number : 471
Status : Valid
NDC Package Code : 52416-111
Start Marketing Date : 2009-06-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14426
Submission : 1999-09-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-01-08
Pay. Date : 2015-12-21
DMF Number : 15684
Submission : 2001-10-19
Status : Active
Type : II
NDC Package Code : 63586-0002
Start Marketing Date : 2011-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20g/20g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12775
Submission : 1997-12-02
Status : Inactive
Type : II
Certificate Number : R1-CEP 1997-091 - Rev 03
Issue Date : 2022-02-07
Type : Chemical
Substance Number : 471
Status : Valid
NDC Package Code : 63586-0002
Start Marketing Date : 2011-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20g/20g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8013
Submission : 1989-04-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7169
Submission : 1987-09-14
Status : Inactive
Type : II
We have 24 companies offering Calcitonin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?